NEXUS BIOPHARMA INC — key financial figures for fiscal year 2017 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Cash Flows from Operating Activities (FY2017)

-$492.4K

Source: NEXUS BIOPHARMA INC 10-K filing (FY2017). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.